ERIN WARNING: Open Payments
NPI 1447772983 · SPRINGVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 45 payments from 16 companies in 2025. Trend: 2023 $1,145 · 2024 $935 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $247 |
| Lilly USA, LLC | 8 | $125 |
| Exact Sciences Corporation | 5 | $108 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| Novo Nordisk Inc | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Amgen Inc. | 3 | $49 |
| Edwards Lifesciences Corporation | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
Products named: BREZTRI, MOUNJARO, SHINGRIX, Cologuard Collection Kit, VOQUEZNA, CAPLYTA, XIFAXAN, Wegovy.
Industry payments across NY — which companies pay providers there.
